ScholarIQanswers from OpenAlex

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases

PaperCitations, authors & open-access status

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases have?

ScholarIQcitation count

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases has 15 citations in the OpenAlex counts ScholarIQ stores.

When was Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases published?

ScholarIQyear

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases has 2018 year in the ScholarIQ index.

What is the open-access status of Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases?

ScholarIQoa status

Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases has closed oa status in the ScholarIQ index.

What is the DOI of Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases?

ScholarIQdoi

The DOI for Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases is on the source record.

What is the PMID of Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases?

ScholarIQpmid

The PMID for Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases is on the source record.

What is the OpenAlex record for Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases?

ScholarIQopenalex

The OpenAlex for Neutrophil Lymphocyte Ratio and Transarterial Chemoembolization in Neuroendocrine Tumor Metastases is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial